Two-dose measles immunization as a strategy to eliminate measles in the Middle East and Israel
Related Experiment Video
Updated: Jun 29, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Ilana Belmaker1, Elina Bazarsky, Larissa Dukhan
1Division of Health in the Community, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. ilana.belmaker@bsh.health.gov.il
Abstract:
The data presented above show that most countries of the Middle East (Israel and countries of the Eastern Mediterranean Region of the WHO) are progressing towards achieving WHO goals for improving immunization coverage for measles immunization to over 90%, along with the introduction of a two-dose immunization strategy. There has been corresponding progress in the reduction of incidence of measles. However, the goal of the WHO to eliminate measles has not been achieved and is unlikely to be in the near future.
More Related Videos
Related Concept Videos
Smallpox
Vaccinations
Respiratory Syncytial Virus Disease
Poliomyelitis
Vaccines
Diphtheria

